A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer

Small-cell lung cancer (SCLC) is a highly invasive and rapidly proliferating pathologic subtype that accounts for 13–15% of all lung cancer cases. Recently in extensive-stage SCLC, treatments that combine immunotherapy and chemotherapy showed increased efficacy compared to chemotherapy alone in seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jeong Uk, Kang, Hye Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246157/
https://www.ncbi.nlm.nih.gov/pubmed/34268422
http://dx.doi.org/10.21037/atm-21-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246157/
https://www.ncbi.nlm.nih.gov/pubmed/34268422
http://dx.doi.org/10.21037/atm-21-68

Ejemplares similares